AI Article Synopsis

Article Abstract

Substance P caused marked analgesic activity in rats after intraventricular administration and in mice after intraperitoneal injection. The hexapeptide pGlu6(SP6-11) was active in mice, but not in rats. Depletion of serotonin with p-chlorophenylalanine abolished the antinociceptive activity in mice, but not in rats, whereas lesion of raphe nuclei blocked the activity of substance P in the latter animals. Although different routes of administration were used, the results seem to indicate different mechanisms of analgesic activity of both peptides in rats and mice, as well as the different role of serotonergic transmission in pain control mechanisms in both species.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0091-3057(81)90096-4DOI Listing

Publication Analysis

Top Keywords

hexapeptide pglu6sp6-11
8
analgesic activity
8
mice rats
8
substance hexapeptide
4
pglu6sp6-11 analgesia
4
analgesia serotonin
4
serotonin depletion
4
depletion substance
4
substance caused
4
caused marked
4

Similar Publications

Rapid and Green Anion-Assisted Mechanochemical Peptide Cyclization.

ACS Sustain Chem Eng

January 2025

Department of Chemistry, Faculty of Science, University of Zagreb, Horvatovac 102a, 10000 Zagreb, Croatia.

A novel mechanochemical approach is described for chloride-templated head-to-tail macrocyclization of a pentapeptide and a hexapeptide. This straightforward method allows the solvent-free preparation of cyclopeptides with yields comparable to solution-based approaches without the need for high dilution of the reaction mixture and with significantly reduced reaction times and organic waste amount.

View Article and Find Full Text PDF

Homeodomain Involvement in Nuclear HOX Protein Homo- and Heterodimerization.

Int J Mol Sci

January 2025

Louvain Institute of Molecular Science and Technology, Université catholique de Louvain, 5 (L7.07.10) Place Croix du Sud, 1348 Louvain-la-Neuve, Belgium.

genes play essential roles in patterning the anteroposterior axis of animal embryos and in the formation of various organs. In mammals, there are 39 genes organized into four clusters (HOXA-D) located on different chromosomes. In relationship with their orderly arrangement along the chromosomes, these genes show nested expression patterns which imply that embryonic territories co-express multiple genes along the main body axis.

View Article and Find Full Text PDF

The HOX and PBX genes encode transcription factors that have key roles in development and cancer, both independently and as a heterodimer within a complex of proteins that recognizes specific sequences in DNA and can both activate and repress transcription of target genes. Due to functional redundancy amongst HOX proteins, knock down or knock out studies of individual genes often do not result in an altered phenotype. An alternative approach is to target the interaction between HOX and PBX proteins, which is dependent on a conserved hexapeptide region within HOX.

View Article and Find Full Text PDF

The cyclic human neuropeptide Urotensin II (hU-II) is an important regulatory peptide found in the central nervous system, cardiovascular system, kidney, etc., however, its conformational structure and dynamics in aqueous solutions have not been studied in detail experimentally. In the present study, the structure of hU-II and the mechanism of its adsorption on the electrochemically roughened Ag electrode are investigated using electrochemical surface-enhanced Raman scattering spectroscopy (EC-SERS) in the voltage range from -1.

View Article and Find Full Text PDF

TriHex 2.0-Advancing Skin Health Science and the TriHex Technology.

J Cosmet Dermatol

December 2024

Alastin a Galderma Company, Fort Worth, Texas, USA.

Background: The original TriHex combination-Tripeptide-1 and Hexapeptide-12 (TriHex) encompasses a peptide combination selected for its ability to modulate the extracellular matrix (ECM) by progressively eliminating clumped collagen and elastin fragments and then stimulating replacement with new collagen and elastin. Incorporation of a proprietary, patent-pending Octapeptide-45 (Octa) to the TriHex original provides potential for added benefit based on the peptide's capacity to stimulate hyaluronic acid (HA) and its anticipated added benefit in wound healing. This is named TriHex 2.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!